Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran.
Departments of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Mediators Inflamm. 2021 Jul 31;2021:8437753. doi: 10.1155/2021/8437753. eCollection 2021.
Peritoneal adhesion (PA) is an abnormal connective tissue that usually occurs between tissues adjacent to damaged organs during processes such as surgery. In this study, the anti-inflammatory and antioxidant effects of (PO) were investigated against postoperative-induced peritoneal adhesion.
Thirty healthy male Wistar rats (220 ± 20 g, 6-8 weeks) were randomly divided into four groups: (1) normal, (2) control (induced peritoneal adhesion), and (3) and (4) PO extracts (induced peritoneal adhesion and received 100 or 300 mg/kg/day of PO extract for seven days). Finally, macroscopic and microscopic examinations were performed using different scoring systems and immunoassays in the peritoneal lavage fluid.
We found that the levels of adhesion scores and interleukin- (IL-) 1, IL-6, IL-10, tumour necrosis factor- (TNF-) , transforming growth factor- (TGF-) , vascular endothelial growth factor (VEGF), and malondialdehyde (MDA) were increased in the control group. However, PO extract (100 and 300 mg/kg) notably reduced inflammatory (IL-1, IL-6, and TNF-), fibrosis (TGF- ), angiogenesis (VEGF), and oxidative (MDA) factors, while increased anti-inflammatory cytokine IL-10, antioxidant factor glutathione (GSH), compared to the control group.
Oral administration of PO improved postoperational-induced PA by alleviating the oxidative factors, fibrosis, inflammatory cytokines, angiogenesis biomarkers, and stimulating antioxidative factors. Hence, PO can be considered a potential herbal medicine to manage postoperative PA. However, further clinical studies are required to approve the effectiveness of PO.
腹膜粘连(PA)是一种异常的结缔组织,通常在手术等过程中发生在受损器官相邻组织之间。本研究旨在探讨(PO)对术后诱导的腹膜粘连的抗炎和抗氧化作用。
将 30 只健康雄性 Wistar 大鼠(220±20g,6-8 周)随机分为四组:(1)正常组,(2)对照组(诱导腹膜粘连),和(3)和(4)PO 提取物组(诱导腹膜粘连并接受 100 或 300mg/kg/天的 PO 提取物治疗七天)。最后,使用不同的评分系统和免疫测定法在腹膜灌洗液中进行宏观和微观检查。
我们发现对照组的粘连评分以及白细胞介素-(IL-)1、IL-6、IL-10、肿瘤坏死因子-(TNF-)、转化生长因子-(TGF-)、血管内皮生长因子(VEGF)和丙二醛(MDA)水平升高。然而,PO 提取物(100 和 300mg/kg)显著降低了炎症(IL-1、IL-6 和 TNF-)、纤维化(TGF-)、血管生成(VEGF)和氧化(MDA)因子,同时增加了抗炎细胞因子 IL-10、抗氧化因子谷胱甘肽(GSH),与对照组相比。
PO 口服给药可通过减轻氧化因子、纤维化、炎症细胞因子、血管生成生物标志物并刺激抗氧化因子来改善术后诱导的 PA。因此,PO 可以被认为是一种潜在的草药来管理术后 PA。然而,需要进一步的临床研究来证实 PO 的有效性。